Skip to main content

Advertisement

SpringerLink
Log in

Non-ICU Hospital Care of Diabetes Mellitus in the Elderly Population

  • Hospital Management of Diabetes (GE Umpierrez, Section Editor)
  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

Abstract

The concept of lower is better when considering the goal for glycemic control in patients with diabetes mellitus has recently been challenged due to recent studies, such as ACCORD, ADVANCE, and VADT, which have observed increased morbidity and mortality from intensive control, especially in older adults, and in those with long duration of diabetes disease and chronic complications. Although evidence in younger patients suggest that blood glucose levels should not be above 180 mg/dl (10.0 mmol/l), there are many unanswered questions and controversies regarding the benefits and risks, methods to achieve and maintain these levels while avoiding hypoglycemia (<70 mg% (3.9 mmol/l)) in the older population. Since the population is aging with a greater life expectancy, it is crucial that these questions be answered. Although several studies of inpatient non-ICU diabetes management have been published, few include older patients. This review will examine available recommendations and explore those controversies regarding non-ICU hospital management in this vulnerable patient population. Additional conditions that impact upon achieving glycemic control will also be discussed. Finally, the older individual has many special needs which may be more important to consider than in young or middle-aged individuals, when transitioning care from in-hospital to home in a patient-centered approach, as recommended by the American Diabetes Association (ADA) and European Society for the Study of Diabetes (EASD).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Association AMD. Diabetes management in the long-term care setting clinical practice guideline. In: Columbia, MD: AMDA; 2008; revised 2010.

  2. Centers for Disease Control and Prevention. National diabetes statistics report: estimates of diabetes and its burden in the United States, 2014. Atlanta Georgia: U.S. Department of Health and Human Services; 2014.

  3. National Diabetes Fact Sheet. General information and national estimates on diabetes in United States. In: U.S. Department of Health and Human Services CDC (ed.) Atlanta, GA; 2011. This data sheet has the current prevalence of diabetes in various age groups and shows the burden of the disease and its complications in the U.S.

  4. Boyle JP, Thompson TJ, Gregg EW, et al. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metrics. 2010;8:29.

    Article  Google Scholar 

  5. Narayan KM, Boyle JP, Geiss LS, et al. Impact of recent increase in incidence on future diabetes burden: U.S., 2005–2050. Diabetes Care. 2006;29:2114–6.

    Article  PubMed  Google Scholar 

  6. DIAMOND project group. Incidence and trends of childhood type 1 diabetes worldwide 1990–1999. Diabet Med. 2006;23:857–66.

    Article  Google Scholar 

  7. Patterson CC, Dahlquist GG, Gyürüs E, Green A, Soltész G. EURODIAB study group. Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective registration study. Lancet. 2009;373:2027–33.

    Article  PubMed  Google Scholar 

  8. Dhaliwal R, Weinstock RS. Management of type 1 diabetes in older adults. Diabetes Spectrum. 2014;27(1):9–20. doi:10.2337/diaspect.27.1.9. This article describes specific management issues important for elderly Type 1 diabetes care.

    Article  Google Scholar 

  9. Turner R, Stratton I, Horton V, Manley S, Zimmet P, Mackay IR, et al. Autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. Lancet. 1997;50:1288–93.

    Article  Google Scholar 

  10. Schutt M, Fach EM, Seufert J, Kerner W, Lang W, Zeyfang A, et al. DPV Initiative and the German BMBF competence network diabetes network: multiple complications and frequent severe hypoglycaemia in ‘elderly’ and ‘old’ patients with type 1 diabetes. Diabet Med. 2012;29:e176–9.

    Article  CAS  PubMed  Google Scholar 

  11. Szoke E, Shrayyef MZ, Messing S, et al. Effect of aging on glucose homeostasis: accelerated deterioration of beta-cell function in individuals with impaired glucose tolerance. Diabetes Care. 2008;31:539–43.

    Article  CAS  PubMed  Google Scholar 

  12. Chang AM, Halter JB. Aging and insulin secretion. Am J Physiol Endocrinol Metab. 2003;284:E7–E12.

    Article  CAS  PubMed  Google Scholar 

  13. Brown AF, Mangione CM, Saliba D, et al. California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders with Diabetes. Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc. 2003;51(Suppl Guidelines):S265–80.

    PubMed  Google Scholar 

  14. Selvin E, Coresh J, Brancati FL. The burden and treatment of diabetes in elderly individuals in the US. Diabetes Care. 2006;29:2415–9.

    Article  PubMed  Google Scholar 

  15. Li Y, Burrows NR, Gregg EW, et al. Declining rates of hospitalization for nontraumatic lower-extremity amputation in the diabetic population aged 40 years or older: U.S., 1988–2008. Diabetes Care. 2012;35:273–7.

  16. Weinstock RS, Xing D, Maahs DM, Michels A, Rickels MR, Peters AL, et al. Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: results from the T1D Exchange Clinic Registry. J Clin Endocrinol Metab. 2013;98:3411–9.

    Article  CAS  PubMed  Google Scholar 

  17. Weir, LM, (Thomson Reuters) Pfuntner A (Thomson Reuters) and Steiner C (AHRQ). Hospital Utilization among Oldest Adults, 2008. HCUP Statistical Brief #103. December 2010, Agency for Healthcare Research and Quality, Rockville, MD. http://www.hcup-us.ahrq.gov/reports/statbriefs/sb103.pdf.

  18. American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care. 2013;36:1033–46.

    Article  PubMed Central  Google Scholar 

  19. Zhuo X, Zhang P, Barker L, Albright A, Thompson TJ, Gregg E. The lifetime cost of diabetes and its implications for diabetes prevention. Diabetes Care. 2014;37:2557–64. doi:10.2337/dc13=2484.

    Article  PubMed  Google Scholar 

  20. Reers C, Erbel S, Esposito I, et al. Impaired islet turnover in human donor pancreata with aging. Eur J Endocrinol. 2009;160:185–91.

    Article  CAS  PubMed  Google Scholar 

  21. Maedler K, Schumann DM, Schulthess F, et al. Aging correlates with decreased beta-cell proliferative capacity and enhanced sensitivity to apoptosis: a potential role for Fas and pancreatic duodenal homeobox-1. Diabetes. 2006;55:2455–62.

    Article  CAS  PubMed  Google Scholar 

  22. Rankin MM, Kushner JA. Adaptive b-cell proliferation is severely restricted with advanced age. Diabetes. 2009;58:1365–72.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  23. Meneilly GS. The pathophysiology of diabetes in the elderly. In: Medha N, Munshi LAL, editors. Geriatric diabetes. New York: Informa Healthcare; 2007. p. 29–36.

    Chapter  Google Scholar 

  24. Aaditya S, Segal AR, Munshi MN. Diabetes Long Term Care Facil Curr Diab Rep. 2014;14:464. doi:10.1007/s11892-013-0464-y.

    Google Scholar 

  25. Zeyda M, Stulnig TM. Obesity, inflammation, and insulin resistance—a mini-review. Gerontology. 2009;55:379–86.

    Article  CAS  PubMed  Google Scholar 

  26. Amati F, Dube JJ, Coen PM, et al. Physical inactivity and obesity underlie the insulin resistance of aging. Diabetes Care. 2009;32:1547–9.

    Article  PubMed Central  PubMed  Google Scholar 

  27. Esposito K, Nappo F, Marfella R, et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation. 2002;106:2067–72.

    Article  CAS  PubMed  Google Scholar 

  28. Stentz FB, Umpierrez GE, Cuervo R, Kitabchi AE. Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises. Diabetes. 2004;53:2079–86.

    Article  CAS  PubMed  Google Scholar 

  29. Vlassara H, Palace MR, Palace. Diabetes and advanced glycation endproducts. J Intern Med. 2002;251(2):87–101. doi:10.1046/j.1365-2796.2002.00932.x.

    Article  CAS  PubMed  Google Scholar 

  30. Blaum C. Diabetes mellitus. In: Durso S, Sullivan GM, editors. Geriatric review syllabus: a core curriculum in geriatric medicine. 8th ed. New York: American Geriatric Society; 2013. p. 566–75.

    Google Scholar 

  31. Gates BJ, Walker KM. Physiological changes in older adults and their effect on diabetes treatment. Diabetes Spectrum. 2014;27:20–9. doi:10.2337/diaspect.27.1.20. This article describes the important issues specific to managing geriatric diabetic patients.

    Article  Google Scholar 

  32. Schafer R, Letassy N, Randal D, Dorey C, Haas L, Barrier P. AADE position statement. Special considerations in the management and education of older persons with diabetes. 2009: 1–6. This article considers important diabetic care requirements for older persons with diabetes.

  33. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359–67.

    Article  PubMed  Google Scholar 

  34. Furnary AP, Gao G, Grunkemeier GL, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003;125:1007–21.

    Article  CAS  PubMed  Google Scholar 

  35. Brunkhorst FM, Engel C, Bloos F, German Competence Network Sepsis (SepNet), et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. New Engl J Med. 2008 Jan 10;358(2):125–39.

  36. Griesdale DE, de Souza RJ, van Dam RM, et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ. 2009;180:821–7.

    Article  PubMed Central  PubMed  Google Scholar 

  37. Preiser JC, Devos P, Ruiz-Santana S, et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med. 2009;35:1738–48.

    Article  CAS  PubMed  Google Scholar 

  38. Knowler WC, Fowler SE, Hamman RF, et al. Diabetes prevention program research group. 10-year follow-up of diabetes incidence and weight loss in the diabetes prevention program outcomes study. Lancet. 2009;374:1677–86.

    Article  PubMed  Google Scholar 

  39. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–53.

    Article  Google Scholar 

  40. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352:854–65.

    Article  Google Scholar 

  41. Holman RR, Paul SK, Bethel MA, et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359:1577.

    Article  CAS  PubMed  Google Scholar 

  42. Gerstein HC, Miller ME, Byington RP, et al. Action to control cardiovascular risk in diabetes study group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:2545–59.

    Article  CAS  PubMed  Google Scholar 

  43. Miller ME, Bonds DE, Gerstein HC, ACCORD Investigators, et al. The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study. BMJ. 2010;340:b5444.

    Article  PubMed Central  PubMed  Google Scholar 

  44. Skyler JS, Bergenstal R, Bonow RO, American Diabetes Association; American College of Cardiology Foundation; American Heart Association, et al. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American diabetes association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Diabetes Care. 2009;32:187–92. This position statement provides an analysis of recent studies regarding the question tight glucose control.

    Article  PubMed Central  PubMed  Google Scholar 

  45. Patel A, MacMahon S, Chalmers J, ADVANCE Collaborative Group, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358:2560–72.

    Article  CAS  PubMed  Google Scholar 

  46. Duckworth W, Abraira C, Moritz T, VADT Investigators, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360:129–39.

    Article  CAS  PubMed  Google Scholar 

  47. Duckworth WC, Abraira C, Moritz TE, Investigators of the VADT, et al. The duration of diabetes affects the response to intensive glucose control in type 2 subjects: the VA diabetes Trial. J Diabetes Complications. 2011;25:355–61.

    Article  PubMed  Google Scholar 

  48. Currie CJ, Peters JR, Tynan A, et al. Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study. Lancet. 2010;375:481–9.

    Article  CAS  PubMed  Google Scholar 

  49. Huang ES, Liu JY, Moffet HH, et al. Glycemic control, complications, and death in older diabetic patients: the diabetes and aging study. Diabetes Care. 2011;34:1329–36.

    Article  PubMed Central  PubMed  Google Scholar 

  50. Sechterberger MK, Bosman RJ, Oudemans-van Straaten HM, et al. The effect of diabetes mellitus on the association between measures of glycaemic control and intensive care unit mortality: a retrospective cohort study. Crit Care. 2013;17:R52.

    Article  PubMed Central  PubMed  Google Scholar 

  51. Jacobi J, Bircher N, Krinsley J, et al. Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients. Crit Care Med. 2012;40:3251–76.

    Article  PubMed  Google Scholar 

  52. Eiland L, Goldner L, Drincic A, Desouza C. Inpatient hypoglycemia: a challenge that must be addressed. Curr Diab Rep. 2014;14:445. doi:10.1007/s11892-013-0445-1.

    Article  PubMed  Google Scholar 

  53. Razavi Nematollahi L, Kitabchi AE, Stentz FB, Wan JY, Larijani BA, Tehrani MM, et al. Proinflammatory cytokines in response to insulin-induced hypoglycemic stress in healthy subjects. Metabolism. 2009;58:443–8. doi:10.1016/j.metabol.2008.10.018.

    Article  CAS  PubMed  Google Scholar 

  54. Del Rey A, Roggero E, Randolf A, Mahuad C, McCann S, Rettori V, et al. IL-1 resets glucose homeostasis at central levels. Proc Natl Acad Sci U S A. 2006;103:16039–44. doi:10.1073/pnas.0607076103.

    Article  PubMed Central  PubMed  Google Scholar 

  55. Fisher BM, Hepburn DA, Smith JG, Frier BM. Responses of peripheral blood cells to acute insulin-induced hypoglycaemia in humans: effect of alpha-adrenergic blockade. Horm Metab Res Suppl. 1992;26:109–10.

    CAS  PubMed  Google Scholar 

  56. Fanelli C, Pampanelli S, Epifano L, Rambotti AM, Ciofetta M, Modarelli F, et al. Relative roles of insulin and hypoglycaemia on induction of neuroendocrine responses to, symptoms of, and deterioration of cognitive function in hypoglycaemia in male and female humans. Diabetologia. 1994;37:797–807.

    Article  CAS  PubMed  Google Scholar 

  57. Robinson RT, Harris ND, Ireland RH, Lee S, Newman C, Heller SR. Mechanisms of abnormal cardiac repolarization during insulin-induced hypoglycemia. Diabetes. 2003;52:1469–74.

    Article  CAS  PubMed  Google Scholar 

  58. Desouza CV, Bolli GB, Fonseca V. Hypoglycemia, diabetes, and cardiovascular events. Diabetes Care. 2010;33:1389–94.

    Article  PubMed Central  PubMed  Google Scholar 

  59. Laitinen T, Lyyra-Laitinen T, Huopio H, Vauhkonen I, Halonen T, Hartikainen J, et al. Electrocardiographic alterations during hyperinsulinemic hypoglycemia in healthy subjects. Ann Noninvasive Electrocardiol. 2008;13:97–105. doi:10.1111/j.1542-474X.2008.00208.x.

    Article  PubMed  Google Scholar 

  60. Koivikko ML, Karsikas M, Salmela PI, Tapanainen JS, Ruokonen A, Seppanen T, et al. Effects of controlled hypoglycaemia on cardiac repolarisation in patients with type 1 diabetes. Diabetologia. 2008;51:426–35. doi:10.1007/s00125-007-0902-y.

    Article  CAS  PubMed  Google Scholar 

  61. Bremer JP, Jauch-Chara K, Hallschmid M, et al. Hypoglycemia unawareness in older compared with middle-aged patients with type 2 diabetes. Diabetes Care. 2009;32:1513–7.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  62. Matyka K, Evans M, Lomas J, et al. Altered hierarchy of protective responses against severe hypoglycemia in normal aging in healthy men. Diabetes Care. 1997;20:135–41.

    Article  CAS  PubMed  Google Scholar 

  63. Turchin A, Matheny ME, Shubina M, Scanlon JV, Greenwood B, Pendergrass ML. Hypoglycemia and clinical outcomes in patients with diabetes hospitalized in the general ward. Diabetes Care. 2009;32:1153–7. doi:10.2337/dc08-2127.

    Article  PubMed Central  PubMed  Google Scholar 

  64. Kirkman MS, Briscoe VJ, Clark N, et al. Diabetes in older adults: a consensus report. J Am Geriatr Soc. 2012;60:2342–56. doi:10.1111/jgs.12035. This position paper evaluates evidence and recommendations for treatment decisions of older adults with diabetes.

    Article  Google Scholar 

  65. Elliott MB, Schafers SJ, McGill JB, Tobin GS. Prediction and prevention of treatment-related inpatient hypoglycemia. J Diabetes Sci Technol. 2012;6:302–9.

    Article  PubMed Central  PubMed  Google Scholar 

  66. Cook CB, Kongable GL, Potter DJ, Abad VJ, Leija DE, Anderson M. Inpatient glucose control: a glycemic survey of 126 U.S. hospitals. J Hosp Med. 2009;4:E7–E14. doi:10.1002/jhm.533.

    Article  PubMed  Google Scholar 

  67. Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, et al. American association of clinical endocrinologists and American diabetes association consensus statement on inpatient glycemic control. Endocr Pract. 2009;15:353–69. doi:10.4158/EP09102.RA. This paper provides recommendations for inpatient glycemic control.

    Article  PubMed  Google Scholar 

  68. Workgroup on Hypoglycemia, American Diabetes Association. Defining and reporting hypoglycemia in diabetes: a report from the American diabetes association workgroup on hypoglycemia. Diabetes Care. 2005;28:1245–9. This is a useful guideline to what is defined as hypoglycemia and why and how it can be reported.

    Article  Google Scholar 

  69. Kosiborod M, Inzucchi SE, Goyal A, Krumholz HM, Masoudi FA, Xiao L, et al. Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction. JAMA. 2009;301:1556–64. doi:10.1001/jama.2009.496.

    Article  CAS  PubMed  Google Scholar 

  70. Boucai L, Southern WN, Zonszein J. Hypoglycemia-associated mortality is not drug-associated but linked to comorbidities. Am J Med. 2011;124:1028–35. doi:10.1016/j.amjmed.2011.07.011.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  71. Farrokhi F, Klindukhova O, Chandra P, Peng L, Smiley D, Newton C, et al. Risk factors for inpatient hypoglycemia during subcutaneous insulin therapy in non-critically ill patients with type 2 diabetes. J Diabetes Sci Technol. 2012;6:1022–9.

    Article  PubMed Central  PubMed  Google Scholar 

  72. Maynard G, Wesorick DH, O’Malley C, Inzucchi SE. Society of hospital medicine glycemic control task force. Subcutaneous insulin order sets and protocols: effective design and implementation strategies. J Hosp Med. 2008;3:29–41. doi:10.1002/jhm.354.

    Article  PubMed  Google Scholar 

  73. Desouza CV, Bolli GB, Fonseca V. Hypoglycemia, diabetes, and cardiovascular events. Diabetes Care. 2010;33:1389–94. doi:10.2337/dc09-2082. Useful review of the CVD risk that might be associated with severe hypoglycemia and the mechanisms involved.

    Article  PubMed Central  PubMed  Google Scholar 

  74. Draznin B, Gilden J, Golden SH, Inzucchi SE, for the PRIDE Investigators. Pathways to quality inpatient management: a call to action. Diabetes Care. 2013;36:1807–14. doi:10.2337/dc12-2508. This paper highlights the controversies and unanswered questions regarding inpatient management of diabetes and calls for studies designed to answer these challenges and gaps.

    Article  PubMed Central  PubMed  Google Scholar 

  75. Umpierrez GE, Isaacs SD, Bazargan N, et al. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87:978–82.

    Article  CAS  PubMed  Google Scholar 

  76. Falciglia M, Freyberg RW, Almenoff PL, D’Alessio DA, Render ML. Hyperglycemia related mortality in critically ill patients varies with admission diagnosis. Crit Care Med. 2009;37:3001–9.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  77. Kosiborod M. Blood glucose and its prognostic implications in patients hospitalised with acute myocardial infarction. Diab Vasc Dis Res. 2008;5:269–75.

    Article  PubMed  Google Scholar 

  78. American Diabetes Association. Standards of medical care in diabetes 2014. Diabetes Care. 2014;37 Suppl 1:S14–80.

    Article  Google Scholar 

  79. Umpierrez GE, Palacio A, Smiley D. Sliding scale insulin: myth or insanity? Am J Med. 2007;120:563–7.

    Article  PubMed  Google Scholar 

  80. Baldwin D, Kinnare K, Draznin B, et al. Insulin treatment of hyperglycemia in hospitalized patients receiving total parenteral nutrition (TPN). Diabetes. 2012;61 Suppl 1:A1070.

    Google Scholar 

  81. Dandona P, Mohanty P, Chaudhuri A, Garg R, Aljada A. Insulin infusion in acute illness. J Clin Invest. 2005;115:2069–72.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  82. Dandona P, Aljada A, Mohanty P, Ghanim H, Hamouda W, Assian E, et al. Insulin inhibits intranuclear factor kappa ß and stimulates Ikappaß in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect. J Clin Endocrinol Metab. 2001;86:3257–65.

    CAS  PubMed  Google Scholar 

  83. Umpierrez GE, Hellman R, Korytkowski MT, Kosiborod M, Maynard GA, Montori VM, et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2012;97:16–38. These guidelines provide clinical practice recommendations for management of patients with diabetes mellitus.

    Article  CAS  PubMed  Google Scholar 

  84. Umpierrez GE, Smiley D, Jacobs S, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care. 2011;34:256–61.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  85. Chaudhuri A, Dandona P, Fonseca V. Cardiovascular benefits of exogenous insulin. J Clin Endocrinol Metab. 2012;97:3079–91.

    Article  CAS  PubMed  Google Scholar 

  86. Ng KW, Allen ML, Desai A, Macrae D, Pathan N. Cardioprotective effects of insulin: how intensive insulin therapy may benefit cardiac surgery patients. Circulation. 2012;125:721–8.

    Article  PubMed  Google Scholar 

  87. Umpierrez GE, Smiley D, Hermayer K, Khan A, Olson DE, Newton C, et al. Randomized study comparing a basal-bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes. Basal Plus Trial Diabetes Care. 2013;32:2169–74.

    Article  Google Scholar 

  88. Umpierrez GE, Hor T, Smiley D, Temponi A, Umpierrez D, Ceron M, et al. Comparison of inpatient insulin regimens with detemir plus aspart versus neutral protamine hagedorn plus regular in medical patients with type 2 diabetes. J Clin Endocrinol Metab. 2009;94:564–9.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  89. Rashidee A, Hart J, Chen J, Kumar S. High-alert medications: error prevalence and severity. Available at: http://www.psqh.com/julyaugust-2009/164-data-trends.html.

  90. Maynard G, Lee J, Phillips G, Fink E, Renvall M. Improved inpatient use of basal insulin, reduced hypoglycemia, and improved glycemic control: effect of structured subcutaneous insulin orders and an insulin management algorithm. J Hosp Med. 2009;4:3–15. doi:10.1002/jhm.391.

    Article  PubMed  Google Scholar 

  91. Ib H. Sliding scale insulin: time to stop sliding. JAMA. 2009;301:213–4.

    Article  Google Scholar 

  92. Oyer DS, Shah A, Bettenhausen S. How to manage steroid diabetes in the patient with cancer. J Support Oncol. 2006;4:479–83.

    PubMed  Google Scholar 

  93. Umpierrez GE, Schwartz S. Use of Incretin-based therapy in hospitalized patients with hyperglycemia. Endocrine Practice 2014: (rapid electronic article in press) DOI 10.4158/EPI 13471.RA.

  94. Hirschman KB, Bixby B. Transitions in care from the hospital to home for patients with diabetes. Diabetes Spectrum. 2014;27:192–5.

    Article  Google Scholar 

  95. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA), European Association for the Study of Diabetes (EASD). Diabetes Care. 2012;35:1364–79. These guidelines recommend that diabetes management should be individualized as a patient-centered approach.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  96. Healy SJ, Dawn B, Cara H, Andrew L, Dungan KM. Inpatient diabetes education is associated with less frequent hospital readmission among patients with poor glycemic control. Diabetes Care. 2013;36(10):2960–7. dc13-0108v1 36/10/2960.

    Article  PubMed Central  PubMed  Google Scholar 

  97. American Diabetes Association. Economic consequences of diabetes mellitus in the U.S. in 1997. Diabetes Care. 1998;21:296–309.

    Article  Google Scholar 

Download references

Acknowledgments

The contents of this article do not reflect the views of the JAL FHCC and are the opinion of the authors.

Compliance with Ethics Guidelines

ᅟ

Conflict of Interest

Janice L. Gilden declares that she has been an investigator in multi-center trials for Novo Nordisk and Boehringer Ingelheim, and on the Speaker’s Bureau for Novo Nordisk.

Aditi Gupta declares no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL, 60064, USA

    Janice L. Gilden & Aditi Gupta

  2. Department of Medicine/ Endocrinology Division, Captain James A. Lovell Federal Health Care Center, 3001 Greenbay Road #111E, North Chicago, IL, 60064, USA

    Janice L. Gilden & Aditi Gupta

  3. Presence Saints Mary and Elizabeth Medical Center, Chicago, IL, 60622, USA

    Janice L. Gilden

Authors
  1. Janice L. Gilden
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Aditi Gupta
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Janice L. Gilden.

Additional information

This article is part of the Topical Collection on Hospital Management of Diabetes

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gilden, J.L., Gupta, A. Non-ICU Hospital Care of Diabetes Mellitus in the Elderly Population. Curr Diab Rep 15, 26 (2015). https://doi.org/10.1007/s11892-015-0596-3

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11892-015-0596-3

Keywords

Search

Navigation